Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Rumble to Acquire AI Infrastructure Company Northern Data
-
Rumble Reports Third Quarter 2025 Results
-
Kyivstar reports 20% top-line and EBITDA growth as digital rises to 12% of revenues
-
VEON Raises 2025 Outlook, Robust Revenue and EBITDA Momentum, Direct Digital Revenue up 63% YoY
-
Leishen Energy(LSE) Makes a Strong Debut at ADIPEC Abu Dhabi, Embarking on a New Chapter of Strategic Expansion in the Middle East and International Markets
-
Important Notice to Long-Term Shareholders of Avantor, Inc. (NYSE: AVTR); Humana Inc. (NYSE: HUM); Inspire Medical Systems, Inc. (NYSE: INSP); and Maison Solutions Inc. (NASDAQ: MSS): Grabar Law Offic
-
Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: FX Super One Planned to Enter the Pilot Build and Production Phase at its Hanford Manufacturing Facility as First Batch of Compl
-
AVITA Medical to Host Investor Webinar Briefing
-
Ensurge Micropower ASA - Mandatory Notice of Trade for Primary Insiders
-
Ensurge Micropower ASA - Key information relating to possible repair issue/subsequent offering
-
Ensurge Micropower ASA – Private Placement successfully placed
-
New REDUCE-IT® Aspirin Analysis Presented at AHA Scientific Sessions 2025 Reinforces VASCEPA®/VAZKEPA® (Icosapent Ethyl) Reduced Cardiovascular Events in High-Risk Patients
-
RadNet Reports Third Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA¹ and Revises Upwards 2025 Financial Guidance Ranges
-
Mileo Mykonos by Yasam Ayavefe Opens 2026 Reservations, Adds Direct Price Match and Confirms Small-Pet Stays
-
Radiant Ridge Energy Ltd. Partners with Nordcon Canada Inc. to Power 3MW Modular Hydrocooled Data Centers with On-Site Natural Gas
-
AHA 2025: Late-Breaking Data Reinforce the Prognostic Power of AI-Driven Heartflow Plaque Analysis as the Most Clinically Validated Framework for Coronary Risk Stratification
-
Intermountain Health Research: Targeted Vitamin D3 Supplementation Cuts Risk of Heart Attack Patients Having a Second Heart Attack in Half
-
Early Childhood Education Expert Alyssa Lencioni of Mechanicsburg, PA, Explains Kindergarten Readiness for HelloNation
-
Real Estate Expert Stephanie Remore of Madison, MS, Explains the Biggest Real Estate Mistakes for HelloNation
-
Heating Expert Mike Wilson of Mount Vernon Explains The Most Overlooked Step in Heating Maintenance for HelloNation
-
George Medicines presents long-term efficacy and safety data for single pill triple combination therapy for hypertension at American Heart Association’s Scientific Sessions 2025
-
Monopar Presents New Data and Analyses on Rapidly Improved Copper Balance in Wilson Disease Patients on Tiomolybdate Choline at AASLD - The Liver Meeting® 2025
-
Medera Presents Late-Breaking Data from First-In-Human Gene Therapy Trial for Heart Failure with Preserved Ejection Fraction at American Heart Association Scientific Sessions 2025
-
WhiteBIT Expands in Argentina and Brazil
-
The Bahamas’ Deputy Prime Minister I. Chester Cooper Assumes Vice-Presidency of the United Nations World Tourism Organization General Assembly
-
HVAC Efficiency Expert John Huether Shares Tips on Avoiding Blocked Air Vents in HelloNation
-
Real Estate Expert Marilyn Pearson Adams Shares Three Things You Should Know Before Visiting Spring Hill, FL in HelloNation
-
Occupational Health Expert Kat Parmer of Cheyenne Clarifies DOT Physical Requirements for HelloNation
-
Personal Injury Attorney Joseph Miklos of Garden City Explains How to Protect Your Rights After a New York Car Accident for HelloNation
-
Real Estate Expert Corina Cisneros Shares What to Know Before Buying a Waterfront Home in the Lake Winnipesaukee Region
-
Mutuum Finance (MUTM) Reports Over $18 Million Raised Ahead of Sepolia V1 Launch in Q4 2025
-
New Crypto Mutuum Finance (MUTM) Advances Through Roadmap Phase 2 With Over 17,800 Holders
-
CNH introduces FLEETPRO aftermarket line-up at Agritechnica 2025
-
Cannabis Club Systems Reaches 900-Club Milestone as AI Integration Drives Global Expansion
-
New Benchmark from CCM Institute Warns 80% of Businesses Lack Clear Contract Accountability
-
Intellia Therapeutics Presents Positive Pooled Phase 1/2 Data of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema
-
Stan Taylor Launches The Black Book of Power, Calling for a Consciousness Shift as 60,000 Readers Embrace Counter-Manipulation Training
-
Clinical Data Demonstrating Efficacy of Sotagliflozin in Preserved Ejection Fraction Heart Failure (HFpEF) without Diabetes Presented at American Heart Association (AHA) Annual Scientific Sessions 202
-
Clearwater Wellness Launches World-First Thermoelectric Ice Bath, with Tim Paine Joining as Founding Partner
-
Louis Limited Sets New Standard for Trading Psychology With Dynamic Emotion Tracking Features
-
RZoasis Announces the Launch of RZUSD, a Transparent Stablecoin Amid Growing Shift Away from Centralized Alternatives
-
Telitacicept Achieved Primary Endpoint of Reducing Proteinuria in Stage A of a Phase 3 Clinical Study for IgA Nephropathy in China
-
Monte Rosa Therapeutics Presents Preclinical Data at AHA Scientific Sessions 2025 on the Potential of MRT-8102, a NEK7-directed Molecular Glue Degrader, to Treat Cardiovascular and Cardiometabolic Dis
-
Tenaya Therapeutics Presents Promising Interim Clinical Data from MYPEAK™-1 Phase 1b/2a Clinical Trial of TN-201 Gene Therapy for the Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy
-
Judo Bio’s Megalin-STRIKERs Achieve First Demonstration of Functional Pharmacodynamic Effects from Kidney Selective Gene Silencing in Non-Human Primates
-
Jade Biosciences Presents New Data Demonstrating a Favorable Preclinical Safety Profile of JADE101 and a Translational Analysis of APRIL Mediated Biomarker Responses at the American Society of Nephrol
-
Most Trusted Crypto Casinos USA: Jackbit Leads 2025 Crypto Gaming With Instant Withdrawals & No KYC Access
-
Phase 2 Trials Demonstrating Antithrombotic Effect of Two Novel Regeneron Factor XI Antibodies Presented at American Heart Association Scientific Sessions and Published in The Lancet
-
Acoramidis Significantly Reduces All-cause Mortality in the Overall ATTR-CM Variant and V142I (V122I) Populations
-
BexBack Unlocks No-KYC 100x Leverage With New $100 Bonus for Beginners

